[ O O O O
POTS O O O O
or O O O O
Long O O O O
COVID? O O O O
How O O O O
to O O O O
tell O O O O
the O O O O
difference O O O O
](/medblog/pots-long-covid-research/) O O O O
June O O O O
12, O O O O
2023 O O O O
Everyone Reason 5 O O
age Reason 5 O O
6 Reason 5 O O
months Reason 5 O O
and Reason 5 O O
older Reason 5 O O
is Reason 5 O O
eligible Reason 5 O O
to Reason 5 O O
receive Reason 5 O O
a Reason 5 O O
COVID-19 Reason 5 O O
vaccine Reason 5 O O
in Reason 5 O O
Texas, Reason 5 O O
and Reason 5 O O
we Reason 5 O O
strongly Reason 5 O O
encourage Reason 5 O O
vaccination Reason 5 O O
as Reason 5 O O
your Reason 5 O O
best Reason 5 O O
defense Reason 5 O O
against Reason 5 O O
the Reason 5 O O
SARS-CoV-2 Reason 5 O O
virus Reason 5 O O
and Reason 5 O O
its Reason 5 O O
variants. Reason 5 O O
The O O O O
most O O O O
current O O O O
Pfizer-BioNTech O O O O
and O O O O
Moderna O O O O
COVID-19 O O O O
vaccines O O O O
are O O O O
available O O O O
on O O O O
a O O O O
walk-in O O O O
basis O O O O
for O O O O
people O O O O
ages O O O O
12 O O O O
and O O O O
older O O O O
at O O O O
UT O O O O
Southwestern's O O O O
retail O O O O
pharmacies O O O O
in O O O O
Dallas, O O O O
Frisco, O O O O
and O O O O
Fort O O O O
Worth: O O O O
Vaccine O O O O
information O O O O
for O O O O
children O O O O
6 O O O O
months-11 O O O O
years O O O O
of O O O O
age O O O O
is O O O O
available O O O O
through O O O O
our O O O O
partner O O O O
[Children's O O O O
Health](https://www.childrens.com/covid-19/vaccine/community-vaccination-sites). O O O O
COVID-19 Reason 4 O O
vaccines Reason 4 O O
and Reason 4 O O
booster Reason 4 O O
doses Reason 4 O O
are Reason 4 O O
free Reason 4 O O
to Reason 4 O O
all Reason 4 O O
people Reason 4 O O
living Reason 4 O O
in Reason 4 O O
the Reason 4 O O
United Reason 4 O O
States. Reason 4 O O
You Reason 4 O O
may Reason 4 O O
be Reason 4 O O
asked Reason 4 O O
to Reason 4 O O
show Reason 4 O O
ID Reason 4 O O
or Reason 4 O O
health Reason 4 O O
insurance, Reason 4 O O
but Reason 4 O O
it's Reason 4 O O
not Reason 4 O O
a Reason 4 O O
requirement. Reason 4 O O
We O O O O
look O O O O
forward O O O O
to O O O O
providing O O O O
your O O O O
vaccination. O O O O
If O O O O
you O O O O
have O O O O
questions, O O O O
please O O O O
call O O O O
[214-633-2021](tel:214-633-2021). O O O O
UT Reason 5 O O
Southwestern Reason 5 O O
provides Reason 5 O O
the Reason 5 O O
most Reason 5 O O
recent Reason 5 O O
bivalent Reason 5 O O
Pfizer-BioNTech Reason 5 O O
and Reason 5 O O
Moderna Reason 5 O O
vaccines, Reason 5 O O
which Reason 5 O O
have Reason 5 O O
been Reason 5 O O
created Reason 5 O O
to Reason 5 O O
target Reason 5 O O
the Reason 5 O O
most Reason 5 O O
prominent Reason 5 O O
variants. Reason 5 O O
The Reason 5 O O
Pfizer Reason 5 O O
and Reason 5 O O
Moderna Reason 5 O O
vaccines Reason 5 O O
use Reason 5 O O
what's Reason 5 O O
called Reason 5 O O
[messenger Reason 5 O O
RNA Reason 5 O O
(mRNA)](https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-covid-19-vaccines.html), Reason 5 O O
a Reason 5 O O
synthetic Reason 5 O O
material Reason 5 O O
that Reason 5 O O
carries Reason 5 O O
the Reason 5 O O
genetic Reason 5 O O
code Reason 5 O O
used Reason 5 O O
to Reason 5 O O
make Reason 5 O O
the Reason 5 O O
SARS-CoV-2 Reason 5 O O
spike Reason 5 O O
protein Reason 5 O O
- Reason 5 O O
the Reason 5 O O
part Reason 5 O O
of Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
that Reason 5 O O
attaches Reason 5 O O
to Reason 5 O O
human Reason 5 O O
cells. Reason 5 O O
The Reason 5 O O
mRNA Reason 5 O O
is Reason 5 O O
showing Reason 5 O O
your Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
a Reason 5 O O
part Reason 5 O O
of Reason 5 O O
the Reason 5 O O
virus, Reason 5 O O
so Reason 5 O O
that Reason 5 O O
when Reason 5 O O
your Reason 5 O O
body Reason 5 O O
encounters Reason 5 O O
the Reason 5 O O
whole Reason 5 O O
virus Reason 5 O O
in Reason 5 O O
real-life, Reason 5 O O
it Reason 5 O O
recognizes Reason 5 O O
the Reason 5 O O
invader Reason 5 O O
and Reason 5 O O
is Reason 5 O O
able Reason 5 O O
to Reason 5 O O
mount Reason 5 O O
a Reason 5 O O
quick Reason 5 O O
immune Reason 5 O O
response, Reason 5 O O
activating Reason 5 O O
antibodies Reason 5 O O
(B Reason 5 O O
and Reason 5 O O
T-cells) Reason 5 O O
to Reason 5 O O
fight Reason 5 O O
it. Reason 5 O O
Vaccines Reason 5 O O
using Reason 5 O O
mRNA Reason 5 O O
are Reason 5 O O
relatively Reason 5 O O
new Reason 5 O O
but Reason 5 O O
[the Reason 5 O O
technology Reason 5 O O
has Reason 5 O O
been Reason 5 O O
around Reason 5 O O
for Reason 5 O O
decades](https://www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/) Reason 5 O O
and Reason 5 O O
has Reason 5 O O
been Reason 5 O O
used Reason 5 O O
in Reason 5 O O
treatments Reason 5 O O
for Reason 5 O O
other Reason 5 O O
diseases Reason 5 O O
such Reason 5 O O
as Reason 5 O O
cancer Reason 5 O O
and Reason 5 O O
cystic Reason 5 O O
fibrosis. Reason 5 O O
While Reason 5 O O
many Reason 5 O O
vaccines Reason 5 O O
use Reason 5 O O
a Reason 5 O O
weakened Reason 5 O O
or Reason 5 O O
inactive Reason 5 O O
version Reason 5 O O
of Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
to Reason 5 O O
create Reason 5 O O
an Reason 5 O O
immune Reason 5 O O
response, Reason 5 O O
these Reason 5 O O
vaccines Reason 5 O O
don't Reason 5 O O
so Reason 5 O O
there Reason 5 O O
is Reason 5 O O
no Reason 5 O O
risk Reason 5 O O
of Reason 5 O O
them Reason 5 O O
causing Reason 5 O O
disease. Reason 5 O O
In O O O O
fall O O O O
2022, O O O O
the O O O O
FDA O O O O
authorized O O O O
reformulated O O O O
"bivalent" O O O O
vaccines O O O O
from O O O O
Pfizer-BioNTech O O O O
and O O O O
Moderna O O O O
that O O O O
target O O O O
the O O O O
most O O O O
prominent O O O O
variants O O O O
of O O O O
the O O O O
original O O O O
SARS-CoV-2 O O O O
virus. O O O O
The Reason 5 O O
Pfizer Reason 5 O O
and Reason 5 O O
Moderna Reason 5 O O
vaccines Reason 5 O O
were Reason 5 O O
nearly Reason 5 O O
95% Reason 5 O O
effective Reason 5 O O
in Reason 5 O O
preventing Reason 5 O O
symptomatic Reason 5 O O
COVID-19 Reason 5 O O
in Reason 5 O O
Phase Reason 5 O O
3 Reason 5 O O
clinical Reason 5 O O
trials Reason 5 O O
in Reason 5 O O
December Reason 5 O O
2020, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
the Reason 5 O O
FDA. Reason 5 O O
The Reason 5 O O
protection Reason 5 O O
from Reason 5 O O
the Reason 5 O O
original Reason 5 O O
two-dose Reason 5 O O
primary Reason 5 O O
series Reason 5 O O
wanes Reason 5 O O
over Reason 5 O O
time, Reason 5 O O
which Reason 5 O O
is Reason 5 O O
why Reason 5 O O
booster Reason 5 O O
doses Reason 5 O O
were Reason 5 O O
approved Reason 5 O O
to Reason 5 O O
bring Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
back Reason 5 O O
to Reason 5 O O
robust Reason 5 O O
levels. Reason 5 O O
People Reason 5 O O
who Reason 5 O O
have Reason 5 O O
received Reason 5 O O
the Reason 5 O O
primary Reason 5 O O
vaccine Reason 5 O O
series Reason 5 O O
and Reason 5 O O
subsequent Reason 5 O O
boosters Reason 5 O O
are Reason 5 O O
much Reason 5 O O
less Reason 5 O O
likely Reason 5 O O
to Reason 5 O O
experience Reason 5 O O
severe Reason 5 O O
symptoms, Reason 5 O O
hospitalization, Reason 5 O O
or Reason 5 O O
death Reason 5 O O
than Reason 5 O O
people Reason 5 O O
who Reason 5 O O
are Reason 5 O O
not Reason 5 O O
vaccinated Reason 5 O O
against Reason 5 O O
COVID-19. Reason 5 O O
Vaccines Reason 5 O O
remain Reason 5 O O
the Reason 5 O O
best Reason 5 O O
protection Reason 5 O O
against Reason 5 O O
severe Reason 5 O O
COVID-19 Reason 5 O O
illness Reason 5 O O
and Reason 5 O O
hospitalization. Reason 5 O O
The O O O O
emergence O O O O
of O O O O
variants, O O O O
such O O O O
as O O O O
Delta O O O O
and O O O O
Omicron, O O O O
has O O O O
only O O O O
reinforced O O O O
the O O O O
importance O O O O
of O O O O
getting O O O O
vaccinated. O O O O
The Reason 5 O O
current Reason 5 O O
vaccines Reason 5 O O
have Reason 5 O O
been Reason 5 O O
reformulated Reason 5 O O
to Reason 5 O O
target Reason 5 O O
the Reason 5 O O
most Reason 5 O O
prominent Reason 5 O O
Omicron Reason 5 O O
subvariants. Reason 5 O O
The Reason 5 O O
vaccines Reason 5 O O
appear Reason 5 O O
to Reason 5 O O
maintain Reason 5 O O
high Reason 5 O O
efficacy Reason 5 O O
rates Reason 5 O O
regardless Reason 5 O O
of Reason 5 O O
age, Reason 5 O O
sex, Reason 5 O O
and Reason 5 O O
ethnicity. Reason 5 O O
For Reason 5 O O
example, Reason 5 O O
Pfizer's Reason 5 O O
vaccine Reason 5 O O
was Reason 5 O O
94% Reason 5 O O
effective Reason 5 O O
in Reason 5 O O
adults Reason 5 O O
over Reason 5 O O
age Reason 5 O O
65, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
safety Reason 5 O O
data. Reason 5 O O
The Reason 5 O O
vaccines Reason 5 O O
have Reason 5 O O
also Reason 5 O O
been Reason 5 O O
tested Reason 5 O O
in Reason 5 O O
people Reason 5 O O
with Reason 5 O O
stable Reason 5 O O
pre-existing Reason 5 O O
conditions Reason 5 O O
such Reason 5 O O
as Reason 5 O O
diabetes Reason 5 O O
and Reason 5 O O
cancer, Reason 5 O O
and Reason 5 O O
efficacy Reason 5 O O
rates Reason 5 O O
held Reason 5 O O
at Reason 5 O O
essentially Reason 5 O O
the Reason 5 O O
same Reason 5 O O
levels. Reason 5 O O
In O O O O
April O O O O
2023, O O O O
the O O O O
CDC O O O O
recommended O O O O
that O O O O
adults O O O O
65 O O O O
and O O O O
older O O O O
and O O O O
those O O O O
with O O O O
weakened O O O O
immune O O O O
systems O O O O
receive O O O O
another O O O O
booster O O O O
dose O O O O
of O O O O
the O O O O
reformulated O O O O
booster O O O O
that O O O O
debuted O O O O
in O O O O
fall O O O O
2022. O O O O
It's O O O O
unclear O O O O
how O O O O
long O O O O
natural O O O O
immunity O O O O
lasts O O O O
after O O O O
recovering O O O O
from O O O O
COVID-19, O O O O
so Reason 4 O O
the Reason 4 O O
CDC Reason 4 O O
advises Reason 4 O O
people Reason 4 O O
to Reason 4 O O
get Reason 4 O O
a Reason 4 O O
vaccine Reason 4 O O
even Reason 4 O O
if Reason 4 O O
they Reason 4 O O
have Reason 4 O O
been Reason 4 O O
sick Reason 4 O O
with Reason 4 O O
COVID-19 Reason 4 O O
before. Reason 4 O O
Vaccinology O O O O
is O O O O
one O O O O
of O O O O
the O O O O
safest O O O O
interventions O O O O
we O O O O
have O O O O
in O O O O
patient O O O O
care O O O O
and O O O O
disease O O O O
prevention, O O O O
and O O O O
it O O O O
has O O O O
a O O O O
long O O O O
history O O O O
of O O O O
protecting O O O O
the O O O O
public O O O O
- O O O O
from O O O O
smallpox O O O O
to O O O O
polio O O O O
to O O O O
measles. O O O O
The Reason 5 O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
have Reason 5 O O
now Reason 5 O O
been Reason 5 O O
given Reason 5 O O
to Reason 5 O O
hundreds Reason 5 O O
of Reason 5 O O
millions Reason 5 O O
of Reason 5 O O
people Reason 5 O O
around Reason 5 O O
the Reason 5 O O
world, Reason 5 O O
and Reason 5 O O
serious Reason 5 O O
side Reason 5 O O
effects Reason 5 O O
have Reason 5 O O
been Reason 5 O O
extremely Reason 5 O O
rare. Reason 5 O O
There Reason 5 O O
are Reason 5 O O
low-grade Reason 5 O O
side Reason 5 O O
effects, Reason 5 O O
such Reason 5 O O
as Reason 5 O O
arm Reason 5 O O
soreness, Reason 5 O O
fatigue, Reason 5 O O
and Reason 5 O O
fever, Reason 5 O O
but Reason 5 O O
they Reason 5 O O
are Reason 5 O O
minor Reason 5 O O
compared Reason 5 O O
with Reason 5 O O
the Reason 5 O O
protections Reason 5 O O
that Reason 5 O O
a Reason 5 O O
safe Reason 5 O O
and Reason 5 O O
effective Reason 5 O O
COVID-19 Reason 5 O O
vaccine Reason 5 O O
or Reason 5 O O
booster Reason 5 O O
shot Reason 5 O O
can Reason 5 O O
provide. Reason 5 O O
There O O O O
is O O O O
a O O O O
well-established O O O O
testing O O O O
and O O O O
clinical O O O O
trial O O O O
regimen O O O O
that O O O O
must O O O O
be O O O O
followed O O O O
for O O O O
the O O O O
FDA O O O O
to O O O O
consider O O O O
approving O O O O
a O O O O
vaccine. O O O O
For O O O O
these O O O O
COVID-19 O O O O
vaccines, O O O O
the O O O O
research O O O O
was O O O O
performed O O O O
concurrently, O O O O
rather O O O O
than O O O O
consecutively, O O O O
and O O O O
the O O O O
wait O O O O
times O O O O
for O O O O
review O O O O
of O O O O
the O O O O
research O O O O
were O O O O
substantially O O O O
reduced O O O O
through O O O O
[Operation O O O O
Warp O O O O
Speed](https://www.defense.gov/Explore/Spotlight/Coronavirus/Operation-Warp-Speed/), O O O O
a O O O O
federal O O O O
program O O O O
that O O O O
invested O O O O
in O O O O
development O O O O
and O O O O
manufacturing O O O O
of O O O O
the O O O O
vaccines. O O O O
No O O O O
steps O O O O
were O O O O
skipped, O O O O
and O O O O
safety O O O O
was O O O O
not O O O O
sacrificed O O O O
for O O O O
speed. O O O O
An O O O O
independent O O O O
and O O O O
transparent O O O O
monitoring O O O O
board O O O O
of O O O O
experts O O O O
reviewed O O O O
the O O O O
trial O O O O
data, O O O O
and O O O O
career O O O O
scientists O O O O
evaluated O O O O
it O O O O
at O O O O
the O O O O
FDA. O O O O
Clinical O O O O
trial O O O O
information O O O O
has O O O O
been O O O O
published O O O O
in O O O O
[peer-reviewed O O O O
journals](https://www.nejm.org/doi/full/10.1056/NEJMoa2034577). O O O O
Vaccines O O O O
are O O O O
typically O O O O
tested O O O O
in O O O O
adults O O O O
first O O O O
to O O O O
ensure O O O O
they're O O O O
safe O O O O
before O O O O
pediatric O O O O
trials O O O O
begin. O O O O
While O O O O
historically, O O O O
pregnant O O O O
women O O O O
have O O O O
not O O O O
been O O O O
included O O O O
in O O O O
vaccine O O O O
trials, O O O O
a O O O O
small O O O O
number O O O O
of O O O O
women O O O O
in O O O O
the O O O O
Pfizer O O O O
clinical O O O O
trial O O O O
became O O O O
pregnant O O O O
during O O O O
the O O O O
study, O O O O
without O O O O
any O O O O
short-term O O O O
complications. O O O O
The Reason 5 O O
Advisory Reason 5 O O
Committee Reason 5 O O
on Reason 5 O O
Immunization Reason 5 O O
Practices Reason 5 O O
and Reason 5 O O
the Reason 5 O O
American Reason 5 O O
College Reason 5 O O
of Reason 5 O O
Obstetricians Reason 5 O O
and Reason 5 O O
Gynecologists Reason 5 O O
have Reason 5 O O
strongly Reason 5 O O
recommended Reason 5 O O
that Reason 5 O O
women Reason 5 O O
who Reason 5 O O
are Reason 5 O O
pregnant, Reason 5 O O
wanting Reason 5 O O
to Reason 5 O O
become Reason 5 O O
pregnant, Reason 5 O O
or Reason 5 O O
breastfeeding Reason 5 O O
receive Reason 5 O O
the Reason 5 O O
COVID-19 Reason 5 O O
vaccines. Reason 5 O O
Studies Reason 5 O O
have Reason 5 O O
shown Reason 5 O O
that Reason 5 O O
the Reason 5 O O
benefits Reason 5 O O
of Reason 5 O O
vaccination Reason 5 O O
for Reason 5 O O
pregnant Reason 5 O O
women Reason 5 O O
and Reason 5 O O
their Reason 5 O O
babies Reason 5 O O
outweigh Reason 5 O O
potential Reason 5 O O
risks Reason 5 O O
and Reason 5 O O
the Reason 5 O O
vaccine Reason 5 O O
can Reason 5 O O
prevent Reason 5 O O
severe Reason 5 O O
illness, Reason 5 O O
death, Reason 5 O O
and Reason 5 O O
pregnancy Reason 5 O O
complications Reason 5 O O
related Reason 5 O O
to Reason 5 O O
COVID-19. Reason 5 O O
Women O O O O
who O O O O
have O O O O
more O O O O
questions O O O O
should O O O O
discuss O O O O
COVID-19 O O O O
vaccination O O O O
with O O O O
their O O O O
personal O O O O
physician. O O O O
Severe O O O O
allergic O O O O
reactions O O O O
to O O O O
vaccines O O O O
are O O O O
very O O O O
rare, O O O O
even O O O O
for O O O O
people O O O O
who O O O O
have O O O O
a O O O O
history O O O O
of O O O O
allergies O O O O
to O O O O
food, O O O O
pets, O O O O
environmental O O O O
factors, O O O O
or O O O O
oral O O O O
medications. O O O O
Still, O O O O
UT O O O O
Southwestern O O O O
is O O O O
following O O O O
the O O O O
CDC's O O O O
recommendations O O O O
and O O O O
observing O O O O
patients O O O O
for O O O O
15 O O O O
minutes O O O O
in O O O O
a O O O O
safe O O O O
environment O O O O
after O O O O
vaccination O O O O
to O O O O
monitor O O O O
for O O O O
any O O O O
adverse O O O O
effects. O O O O
Patients O O O O
who O O O O
have O O O O
had O O O O
a O O O O
severe O O O O
allergic O O O O
reaction O O O O
to O O O O
a O O O O
vaccine, O O O O
an O O O O
intravenous O O O O
medication, O O O O
or O O O O
an O O O O
injectable O O O O
in O O O O
the O O O O
past O O O O
should O O O O
discuss O O O O
COVID-19 O O O O
vaccination O O O O
with O O O O
their O O O O
provider. O O O O
In O O O O
the O O O O
majority O O O O
of O O O O
cases, O O O O
you O O O O
can O O O O
still O O O O
get O O O O
the O O O O
vaccine O O O O
but O O O O
with O O O O
a O O O O
30-minute O O O O
observation O O O O
period O O O O
instead. O O O O
If O O O O
you've O O O O
had O O O O
a O O O O
severe O O O O
allergic O O O O
reaction O O O O
to O O O O
one O O O O
of O O O O
the O O O O
components O O O O
in O O O O
the O O O O
COVID-19 O O O O
vaccines, O O O O
such O O O O
as O O O O
polyethylene O O O O
glycol O O O O
or O O O O
polysorbate, O O O O
it O O O O
is O O O O
recommended O O O O
that O O O O
you O O O O
do O O O O
NOT O O O O
get O O O O
one O O O O
of O O O O
the O O O O
currently O O O O
available O O O O
COVID-19 O O O O
vaccines. O O O O
Also, O O O O
if O O O O
you've O O O O
had O O O O
a O O O O
severe O O O O
or O O O O
immediate O O O O
allergic O O O O
reaction O O O O
to O O O O
the O O O O
first O O O O
dose O O O O
of O O O O
a O O O O
COVID-19 O O O O
vaccine, O O O O
you O O O O
should O O O O
NOT O O O O
get O O O O
the O O O O
second O O O O
dose O O O O
until O O O O
you O O O O
discuss O O O O
the O O O O
specifics O O O O
of O O O O
the O O O O
reaction O O O O
with O O O O
your O O O O
provider. O O O O
If O O O O
you O O O O
are O O O O
feeling O O O O
unwell O O O O
or O O O O
are O O O O
having O O O O
symptoms O O O O
of O O O O
COVID-19, O O O O
please O O O O
speak O O O O
with O O O O
your O O O O
provider O O O O
who O O O O
may O O O O
recommend O O O O
that O O O O
you O O O O
defer O O O O
your O O O O
vaccination O O O O
until O O O O
a O O O O
later O O O O
date. O O O O
There O O O O
is O O O O
no O O O O
evidence O O O O
or O O O O
reason O O O O
to O O O O
think O O O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
affect Reason 5 O O
fertility, Reason 5 O O
despite Reason 5 O O
some Reason 5 O O
claims Reason 5 O O
to Reason 5 O O
the Reason 5 O O
contrary Reason 5 O O
circulating Reason 5 O O
on Reason 5 O O
the Reason 5 O O
internet. Reason 5 O O
Those O O O O
reports O O O O
are O O O O
rooted O O O O
in O O O O
the O O O O
theory O O O O
that O O O O
because O O O O
the O O O O
SARS-CoV-2 O O O O
spike O O O O
protein O O O O
resembles O O O O
the O O O O
syncytin-1 O O O O
protein, O O O O
which O O O O
is O O O O
crucial O O O O
for O O O O
formation O O O O
of O O O O
the O O O O
placenta, O O O O
the O O O O
COVID-19 O O O O
vaccines O O O O
might O O O O
prompt O O O O
an O O O O
immune O O O O
response O O O O
that O O O O
targets O O O O
the O O O O
placenta O O O O
protein. O O O O
But O O O O
virologists O O O O
say O O O O
the O O O O
two O O O O
proteins O O O O
are O O O O
completely O O O O
unrelated O O O O
and O O O O
not O O O O
similar O O O O
enough O O O O
to O O O O
confuse O O O O
antibodies O O O O
that O O O O
attack O O O O
the O O O O
virus. O O O O
No. O O O O
Although O O O O
these O O O O
drugs O O O O
could O O O O
help O O O O
with O O O O
potential O O O O
side O O O O
effects, O O O O
they O O O O
could O O O O
also O O O O
affect O O O O
your O O O O
immune O O O O
response, O O O O
making O O O O
the O O O O
vaccine O O O O
less O O O O
effective. O O O O
It O O O O
is O O O O
recommended O O O O
that O O O O
you O O O O
take O O O O
them O O O O
after O O O O
your O O O O
vaccine O O O O
only O O O O
if O O O O
you O O O O
are O O O O
experiencing O O O O
pain, O O O O
swelling, O O O O
or O O O O
fever. O O O O
The O O O O
most O O O O
common O O O O
side O O O O
effect O O O O
is O O O O
soreness O O O O
at O O O O
the O O O O
injection O O O O
site O O O O
and O O O O
headache, O O O O
with O O O O
most O O O O
side O O O O
effects O O O O
lasting O O O O
less O O O O
than O O O O
48 O O O O
hours. O O O O
Clinical O O O O
trial O O O O
participants O O O O
reported O O O O
arm O O O O
soreness, O O O O
fatigue, O O O O
chills, O O O O
fever, O O O O
or O O O O
headaches O O O O
that O O O O
lasted O O O O
a O O O O
day O O O O
or O O O O
two, O O O O
most O O O O
often O O O O
after O O O O
the O O O O
second O O O O
shot. O O O O
But O O O O
that O O O O
reaction O O O O
is O O O O
typically O O O O
a O O O O
sign O O O O
that O O O O
the O O O O
vaccine O O O O
is O O O O
working O O O O
- O O O O
triggering O O O O
the O O O O
immune O O O O
response O O O O
(or O O O O
inflammation) O O O O
indicating O O O O
your O O O O
body O O O O
recognizes O O O O
this O O O O
never-before-seen O O O O
pathogen O O O O
and O O O O
is O O O O
mounting O O O O
a O O O O
protective O O O O
response O O O O
against O O O O
it. O O O O
The O O O O
clinical O O O O
trials O O O O
will O O O O
continue O O O O
to O O O O
monitor O O O O
patients O O O O
for O O O O
side O O O O
effects O O O O
long O O O O
after O O O O
patients O O O O
are O O O O
vaccinated. O O O O
The O O O O
state O O O O
of O O O O
Texas O O O O
will O O O O
use O O O O
the O O O O
[Vaccine O O O O
Adverse O O O O
Event O O O O
Reporting O O O O
System](https://vaers.hhs.gov/index.html) O O O O
(VAERS), O O O O
a O O O O
national O O O O
system O O O O
co-managed O O O O
by O O O O
the O O O O
Centers O O O O
for O O O O
Disease O O O O
Control O O O O
and O O O O
Prevention O O O O
(CDC) O O O O
and O O O O
FDA, O O O O
to O O O O
track O O O O
vaccine O O O O
safety O O O O
and O O O O
side O O O O
effects. O O O O
Texas O O O O
will O O O O
also O O O O
employ O O O O
an O O O O
app O O O O
called O O O O
V-safe, O O O O
which O O O O
sends O O O O
vaccine O O O O
recipients O O O O
text O O O O
messages O O O O
and O O O O
check-in O O O O
emails O O O O
to O O O O
keep O O O O
tabs O O O O
on O O O O
their O O O O
health, O O O O
as O O O O
well O O O O
as O O O O
remind O O O O
them O O O O
when O O O O
it's O O O O
time O O O O
to O O O O
get O O O O
their O O O O
second O O O O
shot. O O O O
It Reason 5 O O
is Reason 5 O O
possible Reason 5 O O
to Reason 5 O O
have Reason 5 O O
a Reason 5 O O
delayed Reason 5 O O
reaction Reason 5 O O
or Reason 5 O O
side Reason 5 O O
effect Reason 5 O O
starting Reason 5 O O
more Reason 5 O O
than Reason 5 O O
seven Reason 5 O O
days Reason 5 O O
after Reason 5 O O
your Reason 5 O O
vaccination Reason 5 O O
including Reason 5 O O
fever, Reason 5 O O
body Reason 5 O O
aches, Reason 5 O O
headache, Reason 5 O O
and Reason 5 O O
injection Reason 5 O O
site Reason 5 O O
reactions. Reason 5 O O
Delayed Reason 5 O O
injection Reason 5 O O
site Reason 5 O O
reactions Reason 5 O O
have Reason 5 O O
been Reason 5 O O
reported Reason 5 O O
including Reason 5 O O
pain, Reason 5 O O
swelling, Reason 5 O O
itching, Reason 5 O O
and Reason 5 O O
redness. Reason 5 O O
This Reason 5 O O
is Reason 5 O O
not Reason 5 O O
considered Reason 5 O O
an Reason 5 O O
allergic Reason 5 O O
reaction Reason 5 O O
and Reason 5 O O
does Reason 5 O O
not Reason 5 O O
prevent Reason 5 O O
you Reason 5 O O
from Reason 5 O O
receiving Reason 5 O O
your Reason 5 O O
second Reason 5 O O
vaccination. Reason 5 O O
In Reason 5 O O
addition, Reason 5 O O
these Reason 5 O O
reactions Reason 5 O O
are Reason 5 O O
a Reason 5 O O
positive Reason 5 O O
sign Reason 5 O O
that Reason 5 O O
your Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
is Reason 5 O O
responding Reason 5 O O
to Reason 5 O O
the Reason 5 O O
vaccination. Reason 5 O O
If O O O O
you O O O O
have O O O O
any O O O O
concerns, O O O O
please O O O O
speak O O O O
with O O O O
your O O O O
primary O O O O
care O O O O
provider. O O O O
Phase O O O O
three O O O O
vaccine O O O O
trial O O O O
participants O O O O
were O O O O
monitored O O O O
for O O O O
60 O O O O
days O O O O
after O O O O
receiving O O O O
their O O O O
second O O O O
shot, O O O O
which O O O O
is O O O O
required O O O O
before O O O O
any O O O O
safety O O O O
data O O O O
can O O O O
be O O O O
submitted O O O O
to O O O O
the O O O O
FDA. O O O O
Typically, O O O O
if O O O O
a O O O O
patient O O O O
hasn't O O O O
experienced O O O O
severe O O O O
side O O O O
effects O O O O
in O O O O
60 O O O O
days, O O O O
it O O O O
is O O O O
extremely O O O O
unlikely O O O O
they O O O O
will. O O O O
Long-term O O O O
data O O O O
are O O O O
still O O O O
being O O O O
collected O O O O
by O O O O
the O O O O
CDC O O O O
and O O O O
side O O O O
effects O O O O
continue O O O O
to O O O O
be O O O O
monitored. O O O O
The O O O O
FDA O O O O
documents O O O O
said O O O O
the O O O O
Pfizer O O O O
vaccine O O O O
showed O O O O
95% O O O O
immunity O O O O
seven O O O O
days O O O O
after O O O O
the O O O O
second O O O O
shot O O O O
and O O O O
the O O O O
Moderna O O O O
vaccine O O O O
showed O O O O
94.5% O O O O
immunity O O O O
14 O O O O
days O O O O
after O O O O
the O O O O
second O O O O
shot. O O O O
The O O O O
full O O O O
response O O O O
takes O O O O
time O O O O
to O O O O
develop O O O O
after O O O O
the O O O O
second O O O O
vaccine, O O O O
and O O O O
therefore O O O O
one O O O O
is O O O O
not O O O O
considered O O O O
fully O O O O
vaccinated O O O O
until O O O O
two O O O O
weeks O O O O
after O O O O
the O O O O
second O O O O
dose. O O O O
The O O O O
booster O O O O
is O O O O
necessary O O O O
to O O O O
strengthen O O O O
the O O O O
immune O O O O
response O O O O
and O O O O
provide O O O O
full O O O O
protection. O O O O
Also, O O O O
keep O O O O
in O O O O
mind O O O O
that O O O O
exposure O O O O
is O O O O
still O O O O
possible O O O O
between O O O O
doses, O O O O
so O O O O
continue O O O O
to O O O O
take O O O O
precautions. O O O O
There's O O O O
no O O O O
definitive O O O O
way O O O O
to O O O O
tell O O O O
yet, O O O O
[but O O O O
some O O O O
studies O O O O
have O O O O
indicated O O O O
it O O O O
could O O O O
last O O O O
years, O O O O
even O O O O
decades](https://www.biorxiv.org/content/10.1101/2020.11.15.383323v1). O O O O
The O O O O
research O O O O
showed O O O O
that O O O O
patients O O O O
who O O O O
contracted O O O O
COVID-19 O O O O
early O O O O
in O O O O
2020 O O O O
had O O O O
robust O O O O
antibodies O O O O
six O O O O
months O O O O
later. O O O O
Studies O O O O
of O O O O
survivors O O O O
of O O O O
SARS, O O O O
also O O O O
caused O O O O
by O O O O
a O O O O
coronavirus, O O O O
showed O O O O
that O O O O
participants O O O O
carried O O O O
immune O O O O
cells O O O O
17 O O O O
years O O O O
after O O O O
being O O O O
infected. O O O O
So O O O O
there O O O O
are O O O O
some O O O O
reasons O O O O
to O O O O
be O O O O
encouraged, O O O O
but O O O O
scientists O O O O
will O O O O
need O O O O
to O O O O
continue O O O O
monitoring O O O O
the O O O O
length O O O O
and O O O O
strength O O O O
of O O O O
immune O O O O
responses O O O O
in O O O O
vaccinated O O O O
patients. O O O O
No. Reason 5 O O
The Reason 5 O O
vaccines Reason 5 O O
will Reason 5 O O
not Reason 5 O O
influence Reason 5 O O
the Reason 5 O O
results Reason 5 O O
of Reason 5 O O
PCR Reason 5 O O
or Reason 5 O O
antigen Reason 5 O O
COVID-19 Reason 5 O O
tests, Reason 5 O O
as Reason 5 O O
the Reason 5 O O
vaccine Reason 5 O O
does Reason 5 O O
not Reason 5 O O
contain Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
itself Reason 5 O O
- Reason 5 O O
rather Reason 5 O O
it Reason 5 O O
prompts Reason 5 O O
the Reason 5 O O
body Reason 5 O O
to Reason 5 O O
produce Reason 5 O O
antibodies Reason 5 O O
specific Reason 5 O O
for Reason 5 O O
the Reason 5 O O
spike Reason 5 O O
protein. Reason 5 O O
The Reason 5 O O
spike Reason 5 O O
protein Reason 5 O O
is Reason 5 O O
like Reason 5 O O
a Reason 5 O O
key Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
uses Reason 5 O O
to Reason 5 O O
"unlock" Reason 5 O O
and Reason 5 O O
enter Reason 5 O O
our Reason 5 O O
cells. Reason 5 O O
The Reason 5 O O
PCR Reason 5 O O
and Reason 5 O O
antigen Reason 5 O O
tests Reason 5 O O
look Reason 5 O O
for Reason 5 O O
the Reason 5 O O
genetic Reason 5 O O
code Reason 5 O O
of Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
itself, Reason 5 O O
which Reason 5 O O
is Reason 5 O O
not Reason 5 O O
contained Reason 5 O O
in Reason 5 O O
the Reason 5 O O
vaccine, Reason 5 O O
but Reason 5 O O
rather Reason 5 O O
is Reason 5 O O
only Reason 5 O O
present Reason 5 O O
during Reason 5 O O
the Reason 5 O O
viral Reason 5 O O
infection. Reason 5 O O
June O O O O
12, O O O O
2023 O O O O
September O O O O
12, O O O O
2022 O O O O
